Drug Development Service Targeting TAM Reprogramming

Re-educating of M2-like TAMs to M1-like TAMs

Tumor-associated macrophages (TAMs) are the most common form of immune cell encountered in the tumor microenvironment (TME). In response to environmental stimuli, TAMs exhibit a high degree of plasticity. As an increasing number of TAMs interact with different cytokines in the TME, TAMs undergo a transition from M1-like TAMs to M2-like TAMs. This shift in their characteristics leads to immune suppression and facilitates the progression of the tumor. Reprogramming TAMs to M1-like TAMs will be a promisingly effective strategy in cancer therapy.

Fig.1 The functions of M1 and M2-like macrophages in tumor formation. (Van Dalen, et al., 2018)Fig.1 M1 and M2-like macrophage roles in tumor formation.1

Our Drug Development Service Targeting TAM Reprogramming

To boost the development of anti-cancer therapy, Creative Biolabs has successfully developed an affordable and robust drug development service targeting TAM reprogramming. In our drug development service targeting TAM reprogramming, diverse drug types and several targets involved in different pathways are available to support diverse projects from global customers. At the same time, we also provide virus-based TAM reprogramming services for global customers' convenience. At Creative Biolabs, we provide full-around services to help every customer discover novel high-quality therapeutic drugs as well as deliver a useful tool to aid in global customers' projects.

We provide development services for diverse drug types to generate the desirable drugs in accordance with global customers' distinctive demands:

  • Antibody Drug Development Service
  • Antibody-Drug Conjugates (ADCs) Development Service
  • Small Molecule Drug Development Service
  • Cytotoxic Reactive Oxygen Drug Development Service
  • Immune Checkpoint Inhibitor Drug Development Service

At the same time, we provide multiple types of targets including but limited to the following to aid in our drug development service targeting TAM reprogramming:

Fig.3 Multiple types of targets. (Creative Biolabs Original)

Importantly! We also provide virus-based TAM reprogramming services for global customers' convenience to develop novel anti-cancer drugs.

Highlight Features

For more details about our drug development service targeting TAM reprogramming, please feel free to contact us.

Reference

  1. Van Dalen, Floris J., et al. "Molecular repolarisation of tumour-associated macrophages." Molecules 24.1 (2018): 9.
Online Inquiry
  •  

CONTACT US
(USA)
(UK)
(Germany)
ADDRESS

> Global

ISO 9001 Certified - Creative Biolabs Quality Management System.

Copyright © 2024 Creative Biolabs. All Rights Reserved.